Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Atrial Fibrillation (AF) and Hypertension (HTN)

AF - Atrial Fibrillation Clinical Trial

Official title:
Evaluation of the Safety and Efficacy of Pulmonary Vein Isolation (PVI) Combined With Renal Denervation (RDN) in Patients With Atrial Fibrillation (AF) and Hypertension (HTN)

Status Recruiting

Clinical Trial Summary

The close relationship between the increase of sympathetic tension, AF, and HTN cannot be ignored. In addition, the significant failure rate of PVI (20-50%) in the treatment of AF makes it very necessary to explore the effect of RDN on AF. Therefore, this study aims to compare the effects and safety of PVI alone and PVI combined with RDN with AF combined with HTN, which will open a new chapter for PVI combined with RDN in the treatment of AF.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05841615
Study type	Interventional
Source	The First Affiliated Hospital of Xiamen University
Contact
Status	Recruiting
Phase	N/A
Start date	September 1, 2023
Completion date	April 30, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03750435` - Non-fluoroscopy Ablation of AF/AT	N/A
Completed	`NCT04193813` - Predictors of Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Prospective Cohort Study
Recruiting	`NCT04577859` - Oesophageal Protection Study: A Multicentre Study.	N/A
Not yet recruiting	`NCT05168189` - the Role of Ivabradine in Causing AF in Patients With Chronic Coronary Syndrome